{
    "title": "Roche studies Ocrevus, experimental drug in bid to defend MS franchise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8712897/Roche-studies-Ocrevus-experimental-drug-bid-defend-MS-franchise.html",
    "date": "2020-09-09",
    "keywords": [
        "ms",
        "fenebrutinib",
        "roche",
        "medicine",
        "ppms",
        "trial",
        "approval",
        "disease",
        "zurich",
        "sclerosis",
        "franchise",
        "sanofi",
        "product",
        "drugmaker",
        "minority",
        "statement",
        "wednesday",
        "latestage",
        "ground",
        "novartis",
        "kesimpta",
        "bcell",
        "inhibitor",
        "home",
        "infusion",
        "clinic",
        "ocrevus",
        "production",
        "system",
        "drug",
        "sar442168",
        "activity",
        "midstage",
        "science",
        "goal",
        "progression",
        "chief",
        "officer",
        "levi",
        "garraway",
        "pipeline",
        "update",
        "company",
        "reporting",
        "john",
        "miller",
        "michael"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}